These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 18995970)

  • 1. Parasitic brain infection, endocannabinoids, and schizophrenia.
    Melamede R
    Med Hypotheses; 2009 Feb; 72(2):220-2. PubMed ID: 18995970
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cannabis, cannabinoids and schizophrenia: integration of the evidence.
    Cohen M; Solowij N; Carr V
    Aust N Z J Psychiatry; 2008 May; 42(5):357-68. PubMed ID: 18473254
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The endocannabinoid system as a target for novel anxiolytic and antidepressant drugs.
    Gaetani S; Dipasquale P; Romano A; Righetti L; Cassano T; Piomelli D; Cuomo V
    Int Rev Neurobiol; 2009; 85():57-72. PubMed ID: 19607961
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The immunopathology mechanisms of matrix metalloproteinases in brain infection induced by parasites].
    Sun R; Wu ZD
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2010 Dec; 28(6):468-73. PubMed ID: 21500539
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Basic neuroanatomy and neuropharmacology of cannabinoids.
    Breivogel CS; Sim-Selley LJ
    Int Rev Psychiatry; 2009 Apr; 21(2):113-21. PubMed ID: 19367505
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endocannabinoid system: An overview of its potential in current medical practice.
    Mouslech Z; Valla V
    Neuro Endocrinol Lett; 2009; 30(2):153-79. PubMed ID: 19675519
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuropsychiatric disease and Toxoplasma gondii infection.
    Henriquez SA; Brett R; Alexander J; Pratt J; Roberts CW
    Neuroimmunomodulation; 2009; 16(2):122-33. PubMed ID: 19212132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endocannabinoid signaling as a synaptic circuit breaker in neurological disease.
    Katona I; Freund TF
    Nat Med; 2008 Sep; 14(9):923-30. PubMed ID: 18776886
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological and therapeutic secrets of plant and brain (endo)cannabinoids.
    Hanus LO
    Med Res Rev; 2009 Mar; 29(2):213-71. PubMed ID: 18777572
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endocannabinoid chemical biology: a tool for the development of novel therapies.
    Petrosino S; Ligresti A; Di Marzo V
    Curr Opin Chem Biol; 2009 Jun; 13(3):309-20. PubMed ID: 19457702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. From endocannabinoid profiling to 'endocannabinoid therapeutics'.
    Ligresti A; Petrosino S; Di Marzo V
    Curr Opin Chem Biol; 2009 Jun; 13(3):321-31. PubMed ID: 19497779
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The role of endocannabinoid system in physiological and pathological processes in the eye].
    Nadolska K; Goś R
    Klin Oczna; 2008; 110(10-12):392-6. PubMed ID: 19195174
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic polymorphisms of the endocannabinoid system.
    Norrod AG; Puffenbarger RA
    Chem Biodivers; 2007 Aug; 4(8):1926-32. PubMed ID: 17712834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Parasitic central nervous system infections in immunocompromised hosts: clarification of malaria diagnosis.
    Stauffer WM; Magill A; Kain KC
    Clin Infect Dis; 2006 Jul; 43(1):114-5; author reply 115-6. PubMed ID: 16758433
    [No Abstract]   [Full Text] [Related]  

  • 15. Cannabinoids and psychosis.
    Sewell RA; Ranganathan M; D'Souza DC
    Int Rev Psychiatry; 2009 Apr; 21(2):152-62. PubMed ID: 19367509
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurobiology and systems physiology of the endocannabinoid system.
    Wegener N; Koch M
    Pharmacopsychiatry; 2009 May; 42 Suppl 1():S79-86. PubMed ID: 19434559
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The endocannabinoid system in neuropathological states.
    Orgado JM; Fernández-Ruiz J; Romero J
    Int Rev Psychiatry; 2009 Apr; 21(2):172-80. PubMed ID: 19367511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Developmental exposure to cannabinoids causes subtle and enduring neurofunctional alterations.
    Campolongo P; Trezza V; Palmery M; Trabace L; Cuomo V
    Int Rev Neurobiol; 2009; 85():117-33. PubMed ID: 19607965
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The polarised life of the endocannabinoid system in CNS development.
    Anavi-Goffer S; Mulder J
    Chembiochem; 2009 Jul; 10(10):1591-8. PubMed ID: 19533710
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunodiagnosis of CNS parasitic infections.
    Wilkins PP
    Handb Clin Neurol; 2013; 114():23-36. PubMed ID: 23829899
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.